Suchergebnisse - "Chandran, Kartik"

PubPharm (35)

1

Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies

enthalten in: PLoS pathogens | 2024

von Wirchnianski, A. | Nyakatura, E. | Herbert, A. | +19

2

Broad antibody and T cell responses to Ebola, Sudan, and Bundibugyo ebolaviruses using mono- and multi-valent adjuvanted glycoprotein vaccines

enthalten in: Antiviral research | 2024

von Felgner, J. | Clarke, E. | Hernandez-Davies, J. | +9

3

Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge

enthalten in: Nature communications | 2024

von Hsieh, C. | Leist, S. | Miller, E. | +11

4

A Pan-Ebolavirus Monoclonal Antibody Cocktail Provides Protection Against Ebola and Sudan Viruses

enthalten in: The Journal of infectious diseases | 2023

von Liu, G. | He, S. | Chan, M. | +10

5

A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice

enthalten in: PLoS pathogens | 2022

von Malonis, R. | Georgiev, G. | Haslwanter, D. | +9

6

Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals

enthalten in: EBioMedicine | 2022

von Muena, N. | García-Salum, T. | Pardo-Roa, C. | +18

UpdateOf: medRxiv. 2021 May 18;:. - PMID 34031662

7

Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses

enthalten in: Science translational medicine | 2022

von Mittler, E. | Wec, A. | Tynell, J. | +26

8

Structural basis of synergistic neutralization of Crimean-Congo hemorrhagic fever virus by human antibodies

enthalten in: Science (New York, N.Y.) | 2022

von Mishra, A. | Hellert, J. | Freitas, N. | +11

9

Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response

enthalten in: Nature communications | 2021

von Herman, J. | Wang, C. | Loos, C. | +12

UpdateOf: medRxiv. 2021 Mar 11;:. - PMID 33758875

10

A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants

enthalten in: mBio | 2021

von Haslwanter, D. | Dieterle, M. | Wec, A. | +27